Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy

Immune checkpoint blockade (ICB) has significantly advanced cancer immunotherapy, yet its patient response rates are generally low. Vaccines, including immunostimulant‐adjuvanted peptide antigens, can improve ICB. The emerging neoantigens generated by cancer somatic mutations elicit cancer‐specific...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Ting, Cheng, Furong, Qi, Jialong, Zhang, Yu, Zhou, Shurong, Mei, Lei, Fu, Shiwei, Zhang, Fuwu, Lin, Shuibin, Zhu, Guizhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376841/
https://www.ncbi.nlm.nih.gov/pubmed/35712773
http://dx.doi.org/10.1002/advs.202201895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376841/
https://www.ncbi.nlm.nih.gov/pubmed/35712773
http://dx.doi.org/10.1002/advs.202201895

Ejemplares similares